C000221226 Holdings — BlackRock Future Health ETF
All 58 reported holdings of BlackRock Future Health ETF (C000221226) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Merck & Co Inc | 5.91% | $659.33K |
| Gilead Sciences Inc | 4.86% | $542.32K |
| Johnson & Johnson | 4.49% | $501.16K |
| Edwards Lifesciences Corp | 4.42% | $492.84K |
| Thermo Fisher Scientific Inc | 4.18% | $466.33K |
| Charles River Laboratories International Inc | 3.72% | $414.57K |
| Blackrock Cash Funds Treasury Sl Agency Shares | 3.68% | $410.00K |
| Danaher Corp | 3.63% | $404.97K |
| Biogen Inc | 3.52% | $392.71K |
| Waters Corp | 3.50% | $390.52K |
| Mettler-Toledo International Inc | 3.48% | $388.07K |
| AbbVie Inc | 3.44% | $383.44K |
| Vertex Pharmaceuticals Inc | 2.95% | $329.20K |
| Moderna Inc | 2.92% | $326.07K |
| Dexcom Inc | 2.61% | $291.49K |
| Amgen Inc | 2.49% | $278.09K |
| Bio-Techne Corp | 2.46% | $274.30K |
| Illumina Inc | 2.41% | $268.48K |
| Novartis AG | 2.21% | $246.94K |
| Incyte Corp | 2.12% | $236.77K |
| Roche Holding AG | 2.12% | $236.03K |
| IQVIA Holdings Inc | 1.96% | $218.33K |
| Argenx SE | 1.91% | $213.46K |
| BlackRock Funds III | 1.81% | $201.33K |
| Cytokinetics Inc | 1.80% | $200.54K |
| Neurocrine Biosciences Inc | 1.71% | $190.99K |
| Abbott Laboratories | 1.70% | $189.94K |
| Guardant Health Inc | 1.53% | $170.09K |
| Roivant Sciences Ltd | 1.42% | $157.82K |
| AstraZeneca PLC | 1.33% | $148.44K |
| Bristol-Myers Squibb Co | 1.27% | $141.66K |
| Axsome Therapeutics Inc | 1.27% | $141.48K |
| BioMarin Pharmaceutical Inc | 1.23% | $136.85K |
| Revolution Medicines Inc | 1.22% | $135.58K |
| Wuxi Biologics Cayman Inc | 1.17% | $130.79K |
| Bruker Corp | 1.04% | $115.88K |
| Protagonist Therapeutics Inc | 0.96% | $106.58K |
| Ucb SA | 0.77% | $85.48K |
| Alkermes PLC | 0.75% | $83.87K |
| Apogee Therapeutics Inc | 0.69% | $77.24K |
| Arcus Biosciences Inc | 0.65% | $72.34K |
| Dianthus Therapeutics Inc | 0.62% | $69.60K |
| MBX Biosciences Inc | 0.59% | $65.47K |
| BioNTech SE | 0.57% | $63.86K |
| Cogent Biosciences Inc | 0.57% | $63.53K |
| Insmed Inc | 0.44% | $48.61K |
| Erasca Inc | 0.39% | $43.11K |
| Avalo Therapeutics Inc | 0.13% | $14.25K |
| Halozyme Therapeutics Inc | 0.11% | $12.79K |
| Sagimet Biosciences Inc | 0.11% | $12.00K |
| Eikon Therapeutics Inc | 0.10% | $11.54K |
| Ultragenyx Pharmaceutical Inc | 0.10% | $11.46K |
| Summit Therapeutics Inc | 0.07% | $8.28K |
| Contra Abiomed, Inc. | 0.00% | $374 |
| Contra Mirati Therapeu | 0.00% | $264 |
| Contra Blueprint Medic | 0.00% | $109 |
| Contra Vigil Neuroscie | 0.00% | $24 |
| Contra Frequency Thera | 0.00% | $0 |
C000221226 overview: performance, fees, allocation and SEC filings